PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Acute and Emergency Department, Ca\' Foncello Hospital, Treviso, Italy.\', \'Department of Medicine-DIMED, Medicina Generale I^, Ca\' Foncello Hospital, Treviso, University of Padova, Padua, Italy.\', \'The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.\', \'Department of Surgical, Oncologic and Gastroenterological Sciences (DISCOG), Ca\' Foncello Hospital, Treviso, University of Padua, Padua, Italy.\', \'Department of Specialistic and Laboratory Medicine Pulmonology Unit, Ca\' Foncello Hospital, Treviso, Italy.\', \'Department of Anesthesia and Intensive Care, Ca\' Foncello Hospital, Treviso, Italy.\', \'Department of Medicine, Medicina Generale II^, Ca\' Foncello Hospital, Treviso, Italy.\', \'Department of Specialistic and Laboratory Medicine, Microbiology Unit, Ca\' Foncello Hospital, Treviso, Italy.\', \'O.R.A.S. SpA, Ospedale Riabilitativo di Alta Specializzazione, Motta Di Livenza, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/ajh/hpaa096
?:hasPublicationType
?:journal
  • American journal of hypertension
is ?:pmid of
?:pmid
?:pmid
  • 32511678
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.322
?:rankingScore_hIndex
  • 123
is ?:relation_isRelatedTo_publication of
?:title
  • Use of RAAS Inhibitors and Risk of Clinical Deterioration in COVID-19: Results From an Italian Cohort of 133 Hypertensives.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all